Literature DB >> 11160187

Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function.

T J Yun1, M D Tallquist, A Aicher, K L Rafferty, A J Marshall, J J Moon, M E Ewings, M Mohaupt, S W Herring, E A Clark.   

Abstract

Osteoprotegerin (OPG) is a CD40-regulated gene in B cells and dendritic cells (DCs). We investigated the role of OPG in the immune system by generating opg(-/-) mice. Like its role as a regulator of bone metabolism, OPG also influences processes in the immune system, notably in B cell development. Ex vivo, opg(-/-) pro-B cells have enhanced proliferation to IL-7, and in opg(-/-) spleen, there is an accumulation of type 1 transitional B cells. Furthermore, opg(-/-) bone marrow-derived DCs are more effective in stimulating allogeneic T cells than control DCs. When challenged with a T-dependent Ag, opg(-/-) mice had a compromised ability to sustain an IgG3 Ag-specific response. Thus, in the immune system, OPG regulates B cell maturation and development of efficient Ab responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160187     DOI: 10.4049/jimmunol.166.3.1482

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  Resistance to TRAIL and how to surmount it.

Authors:  Danijela Maksimovic-Ivanic; Stanislava Stosic-Grujicic; Ferdinando Nicoletti; Sanja Mijatovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.

Authors:  C Van Poznak; S S Cross; M Saggese; C Hudis; K S Panageas; L Norton; R E Coleman; I Holen
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

3.  T cells are required for the peripheral phase of B-cell maturation.

Authors:  Novica M Milićević; Klaus Nohroudi; Zivana Milićević; Hans-Juergen Hedrich; Jürgen Westermann
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

4.  Nanoparticulate mineralized collagen glycosaminoglycan materials directly and indirectly inhibit osteoclastogenesis and osteoclast activation.

Authors:  Xiaoyan Ren; Qi Zhou; David Foulad; Marley J Dewey; David Bischoff; Timothy A Miller; Dean T Yamaguchi; Brendan A C Harley; Justine C Lee
Journal:  J Tissue Eng Regen Med       Date:  2019-04-15       Impact factor: 3.963

Review 5.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

6.  Biocompatibility of pure and mixed hydroxyapatite and α-tricalcium phosphate implanted in rabbit bone.

Authors:  Jolanta Vamze; Mara Pilmane; Andrejs Skagers
Journal:  J Mater Sci Mater Med       Date:  2015-01-29       Impact factor: 3.896

7.  T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts.

Authors:  Kehmia Titanji; Aswani Vunnava; Antonina Foster; Anandi N Sheth; Jeffrey L Lennox; Andrea Knezevic; Neeta Shenvi; Kirk A Easley; Ighovwerha Ofotokun; M Neale Weitzmann
Journal:  AIDS       Date:  2018-04-24       Impact factor: 4.177

8.  Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells.

Authors:  Jared J Barrott; Benjamin E Illum; Huifeng Jin; Matthew L Hedberg; Yanliang Wang; Allie Grossmann; Malay Haldar; Mario R Capecchi; Kevin B Jones
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

9.  Predictive Value of Osteoprotegerin and Neutrophil Gelatinase-associated Lipocalin on Multiple Organ Failure in Multiple Trauma.

Authors:  Henning Peters; Christian Macke; Philipp Mommsen; Christian Zeckey; Jan-Dierk Clausen; Christian Krettek; Claudia Neunaber; Marcel Winkelmann
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

10.  In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice.

Authors:  Julie Lacombe; Gerard Karsenty; Mathieu Ferron
Journal:  Mol Metab       Date:  2013-08-15       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.